Compare Repligen Corporation Common Stock (RGEN) vs iShares TIPS Bond ETF (TIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs iShares TIPS Bond ETF — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while iShares TIPS Bond ETF trades at $105.37 (market cap $14.33B). The key difference: iShares TIPS Bond ETF is the larger of the two by market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, iShares TIPS Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and iShares TIPS Bond ETF for 64 Days on average.
| RGEN | TIP | |
|---|---|---|
Market Cap | $11.14B | $14.33B |
Volume | 1,259,263 | 1,485,284 |
Sector | Health | Fixed Income |
52-Week High | $194.57 | $112.20 |
52-Week Low | $102.87 | $103.98 |
Typical Hold Time | 0 Days | 64 Days |
Enterprise Value | $11.02B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
TIP trades at $104.56 with minimal daily movement (+0.06%). Technical indicators show a bearish bias with moving averages signaling caution, though oscillators remain neutral. The ETF shows limited price volatility with support at $104 and resistance at $105. Recent institutional activity includes Envestnet Asset Management increasing its stake by 3.5% in the latest quarter.
The ETF faces headwinds from rising Treasury yields and bond market volatility, though its inflation-protected structure provides defensive characteristics. Key risks include continued bond market selloffs and geopolitical tensions affecting oil prices. The upcoming dividend payment of $0.78 scheduled for August 2026 offers income stability amid market uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About iShares TIPS Bond ETF
TIP is the flagship ETF for U.S. Treasury Inflation-Protected Securities (TIPS). It tracks an index of government bonds whose principal value adjusts based on the Consumer Price Index (CPI), providing a direct hedge against rising inflation.
Read more on TIP →
